E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 1/25/2006 in the Prospect News PIPE Daily.

New Issue: Bio-Key International gets extension on maturity of $7 million in convertible notes

By Sheri Kasprzak

New York, Jan. 25 - Bio-Key International, Inc. said it has received an extension on $7 million in secured convertible notes from Laurus Master Fund Ltd.

The conversion price was also lowered on the notes as well.

The maturity of $5 million in notes issued on Sept. 29, 2004 was extended to Jan. 1, 2008 from Sept. 29, 2007 and the conversion price lowered to $0.85 from $1.35.

The maturity of $2 million in notes issued in June 7, 2005 was extended to Dec. 1, 2008 from June 7, 2008 and the conversion price lowered to $0.85 from $1.35.

Also, the strike price of all warrants issued from the offering was lowered to $1.00 per share.

For the extension, Laurus received warrants for 150,000 shares. The warrants are exercisable at $0.70 each.

Also, the company received an extension on the maturity of $5,288,221 in subordinated convertible promissory notes to Jan. 1, 2009 and $3,244,723 in subordinated convertible promissory notes issued on May 31, 2005 to Jan. 1, 2009. The interest rate on the notes was also reset to 15% and the conversion price was set at $0.70.

Separately, Bio-Key raised $1 million from a private placement of convertible notes with The Shaar Fund, Ltd.; Longview Fund, LP; and Longview Special Finance.

The notes mature Jan. 1, 2009, bear interest at 15% annually and are convertible into series B preferred stock. The preferreds are convertible into common shares at $0.70 each.

The investors also received warrants for 500,000 shares, exercisable at $1.00 each.

Jesup & Lamont Securities Corp. was the placement agent.

Proceeds will be used for working capital.

Based in Wall, N.J., Bio-Key develops finger-based biometric identification and security technologies.

Issuer:Bio-Key International, Inc.
Issue:Convertible notes
Amount:$1 million
Maturity:Jan. 1, 2009
Coupon:15%
Price:Par
Yield:15%
Conversion price:Into series B preferreds, which are convertible into common shares at $0.70
Warrants:For 500,000 shares
Warrant strike price:$1.00
Investors:The Shaar Fund, Ltd.; Longview Fund, LP; and Longview Special Finance
Placement agent:Jesup & Lamont Securities Corp.
Settlement date:Jan. 23
Stock symbol:OTCBB: BKYI
Stock price:$0.85 at close Jan. 23

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.